Vudalimab - Research Grade Biosimilar
Product Specifications
CAS Number
2329669-72-7
NCBI Gene ID
1493
Swiss Prot
P16410
Accession Number
P16410
Immunogen
Humanized / CTLA4, PDCD1
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Other
Purification
>95%
Concentration
Batch dependent
Purity
>95%
Buffer
PBS buffer pH 7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks) . Store at -20 °C 12 months. Store at -80°C long term.
Fragment
Bispecific , IgG1, Kappa; Kappa
Symbol
CTLA4
NCBI Official Name
Cytotoxic T-lymphocyte associated protein 4
NCBI Organism
Homo sapiens
Other Product Names
ANTI-PD-1/ANTI-CTLA-4 XMAB20717, ANTI-PD1/CTLA4 BISPECIFIC ANTIBODY XMAB20717, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI- (HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152) ) AND ANTI- (HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279) ), MONOCLONAL ANTIBODY, BISPECIFIC PD-1 X CTLA-4 DUAL CHECKPOINT INHIBITOR XMAB20717 VUDALIMAB, VUDALIMAB [INN], XMAB20717, XMAB-20717, CD; GSE; GRD4; ALPS5; CD152; CTLA-4; IDDM12; CELIAC3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B233665-5G 5 g
1-Benzyl-4-carboxy-pyridinium Ethyl Ester Bromide
Sign In for Pricing
View Details 
LY433416 100 µg
Kaiso (ZBTB33) (NM_001184742) Human Over-expression Lysate
Sign In for Pricing
View Details 
LC431870 20 µg
WDR51A (POC1A) (NM_001161580) Human Over-expression Lysate
Sign In for Pricing
View Details